These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6351817)

  • 1. The effect of amantadine on arousal and EEG patterns in Creutzfeldt-Jakob disease.
    Terzano MG; Montanari E; Calzetti S; Mancia D; Lechi A
    Arch Neurol; 1983 Sep; 40(9):555-9. PubMed ID: 6351817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease treated with amantadine.
    Sanders WL
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):960-1. PubMed ID: 390098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creutzfeldt-Jakob disease treated with amantidine. A report of two cases.
    Sanders WL; Dunn TL
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):581-4. PubMed ID: 4581346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drugs in Jakob-Creutzfeldt disease.
    Herishanu Y
    J Am Geriatr Soc; 1973 May; 21(5):229-31. PubMed ID: 4575371
    [No Abstract]   [Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease with focal onset unsuccessfully treated with amantadine.
    Ratcliffe J; Rittman A; Wolf S; Verity MA
    Bull Los Angeles Neurol Soc; 1975 Jan; 40(1):18-20. PubMed ID: 1097004
    [No Abstract]   [Full Text] [Related]  

  • 6. Jakob-Creutzfeldt disease: treatment by amantadine.
    Braham J
    Br Med J; 1971 Oct; 4(5781):212-3. PubMed ID: 4940159
    [No Abstract]   [Full Text] [Related]  

  • 7. [Amantadine in Creutzfeldt-Jakob disease. Review of the literature and case contribution].
    Neri G; Figà-Talamanca L; Di Battista GC; Lo Russo F
    Riv Neurobiol; 1984; 30(1):47-56. PubMed ID: 6399949
    [No Abstract]   [Full Text] [Related]  

  • 8. The significance of cyclic EEG changes in Creutzfeldt-Jakob disease: prognostic value of their course in 9 patients.
    Terzano MG; Mancia D; Zacchetti O; Manzoni GC
    Ital J Neurol Sci; 1981 Aug; 2(3):243-54. PubMed ID: 7042644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial EEG findings in sporadic and iatrogenic Creutzfeldt-Jakob disease.
    Wieser HG; Schwarz U; Blättler T; Bernoulli C; Sitzler M; Stoeck K; Glatzel M
    Clin Neurophysiol; 2004 Nov; 115(11):2467-78. PubMed ID: 15465434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine in the treatment of Creutzfeldt-Jakob disease.
    Braham J
    Arch Neurol; 1984 Jun; 41(6):585-6. PubMed ID: 6372758
    [No Abstract]   [Full Text] [Related]  

  • 11. Topographic distribution of the periodic discharges in Creutzfeldt-Jakob disease (CJD).
    Neufeld MY; Korczyn AD
    Brain Topogr; 1992; 4(3):201-6. PubMed ID: 1633058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics and antivirals do not modify experimentally-induced Creutzfeldt-Jakob disease in mice.
    Tateishi J
    J Neurol Neurosurg Psychiatry; 1981 Aug; 44(8):723-4. PubMed ID: 6170735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease.
    Hansen HC; Zschocke S; Stürenburg HJ; Kunze K
    Acta Neurol Scand; 1998 Feb; 97(2):99-106. PubMed ID: 9517859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine in Jakob-Creutzfeldt disease.
    Norris FH
    Br Med J; 1972 May; 2(5809):349. PubMed ID: 4553821
    [No Abstract]   [Full Text] [Related]  

  • 15. Early detection of periodic sharp wave complexes on EEG by independent component analysis in patients with Creutzfeldt-Jakob disease.
    Wang PS; Wu YT; Hung CI; Kwan SY; Teng S; Soong BW
    J Clin Neurophysiol; 2008 Feb; 25(1):25-31. PubMed ID: 18303557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electro-encephalographic study in 25 patients with Creutzfeldt-Jakob's disease (author's transl)].
    Brechet R; Sicard C; Moret-Chalmin C; Olivesi L; Cathala F; Brown P; Cathala HP
    Rev Electroencephalogr Neurophysiol Clin; 1980; 10(1):55-63. PubMed ID: 7008116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease without periodic sharp wave complexes: a clinical, electroencephalographic, and pathologic study.
    Zochodne DW; Young GB; McLachlan RS; Gilbert JJ; Vinters HV; Kaufmann JC
    Neurology; 1988 Jul; 38(7):1056-60. PubMed ID: 3290701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearance of periodic sharp wave complexes in Creutzfeldt-Jakob disease.
    Aguglia U; Gambardella A; Le Piane E; Messina D; Farnarier G; Oliveri RL; Zappia M; Quattrone A
    Neurophysiol Clin; 1997 Sep; 27(4):277-82. PubMed ID: 9350060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal evolution of electroencephalographic abnormalities in Creutzfeldt-Jakob disease.
    Schlenska GK; Walter GF
    J Neurol; 1989 Dec; 236(8):456-60. PubMed ID: 2693620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible association between triphasic E.E.G. waves and disorder of dopaminergic systems.
    Hamoen AM
    Br Med J; 1973 Aug; 3(5874):272-3. PubMed ID: 4579292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.